Showing results (1581-1590 of 2,323) with videos related to
Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|December 16, 2014
The potential of CXCL5 as a target for liver cancer - what do we know so far?Jinglin Xia, Xiaojing Xu, Peixin Huang, et al.Expert Opinion on Therapeutic Targets|October 28, 2014
Antithrombotic therapy: new areas to understand efficacy and bleedingJames W Wisler, Richard C BeckerExpert Opinion on Therapeutic Targets|January 21, 2015
Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancerPetra Popovics, Daniel E Frigo, Andrew V Schally, et al.Expert Opinion on Therapeutic Targets|January 21, 2015
Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far?Juliet Morrison, Michael G KatzeExpert Opinion on Therapeutic Targets|December 31, 2014
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic targetWen-Yue Liu, Dong-Mei Xie, Gui-Qi Zhu, et al.Expert Opinion on Therapeutic Targets|December 5, 2014
FAK/Src family of kinases: protective or aggravating factor for ischemia reperfusion injury in nervous system?Christos Bikis, Demetrios Moris, Ioanna Vasileiou, et al.Expert Opinion on Therapeutic Targets|November 12, 2014
Issues in interpreting the in vivo activity of Aurora-AElena Shagisultanova, Roland L Dunbrack, Erica A GolemisExpert Opinion on Therapeutic Targets|November 23, 2014
Emerging therapeutic targets for Gaucher diseaseEinat B Vitner, Ayelet Vardi, Timothy M Cox, et al.Expert Opinion on Therapeutic Targets|November 12, 2020
The gut microbiome as a target for adjuvant therapy in obstructive sleep apneaMohammad Badran, Saif Mashaqi, David GozalExpert Opinion on Therapeutic Targets|November 3, 2020
Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targetsPanek Małgorzata, Kawalec Paweł, Malinowska Lipień Iwona, et al.Pageof 233